Brad Coelho is an experienced professional in sales and marketing, currently serving as the Head of Sales and Marketing and Senior Director of Market Access at Biovica International AB since December 2022. Prior to this role, Brad held the position of Regional Sales Director at Exagen Inc. from June 2021 to December 2022, and served as National Account Manager at Prometheus Biosciences from July 2019 to June 2021. Brad's extensive career at Prometheus Laboratories Inc., a Nestlé Health Science Company, spanned from January 2012 to July 2019, where roles included District Sales Manager, Executive Technical Sales Specialist, and Senior Technical Sales Specialist. Brad holds a Bachelor of Science degree in Exercise Physiology from the University of New Hampshire, earned between 1998 and 2002, and is a graduate of New Milford High School, completing studies from 1994 to 1998.
This person is not in any teams
This person is not in any offices
Biovica International AB
Biovica develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and predict patient outcomes. The company’s DiviTum™ TKa assay, a test for accurately measuring cell proliferation, has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. Biovica aims to make best-possible-treatment from day one a reality. Biovica collaborates with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies. The company is ISO 13485 certified for Quality Management Systems. DiviTum™ is CE-labeled and MPA-registered.